Evolution of Thrombin Formation and Fibrinolysis Markers, Including Thrombin-Activatable Fibrinolysis Inhibitor, during Severe Meningococcemia

Publisher： Karger

E-ISSN： 1424-8840|34|6|284-287

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.34, Iss.6, 2006-06, pp. : 284-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombin activatable fibrinolysis inhibitor (TAFI)—How does thrombin regulate fibrinolysis?

By Bouma Bonno   Mosnier Laurent  

Annals of Medicine, Vol. 38, Iss. 6, 2006-10 ,pp. : 378-388

Informa Healthcare

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 257-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 256-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 260-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 259-259

John Wiley & Sons Inc

Access to resources Recommend Favorite